Development of a cAdVax-Based Bivalent Ebola Virus Vaccine That Induces Immune Responses against both the Sudan and Zaire Species of Ebola Virus

Affordable Access

Development of a cAdVax-Based Bivalent Ebola Virus Vaccine That Induces Immune Responses against both the Sudan and Zaire Species of Ebola Virus

Publisher
American Society for Microbiology
Publication Date
Source
PMC
Keywords
  • Vaccines And Antiviral Agents
Disciplines
  • Biology
  • Design

Abstract

Statistics

Seen <100 times